Churchill Capital Corp XII (Nasdaq: CXII) is a blank-check special purpose acquisition company that filed its S-1 registration statement with the SEC on April 2, 2026, representing the twelfth vehicle in the long-running Churchill Capital Corp SPAC franchise. The offering is sponsored by Churchill Capital, the firm led by veteran mergers-and-acquisitions banker Michael Klein, whose prior SPAC vehicles have pursued targets across technology, financial services, and healthcare. As of its 2026 filing date, CXII has not yet priced its IPO and remains in the registration phase, seeking a target across broad industry sectors in keeping with the general-purpose mandate typical of the Churchill series. For comprehensive filings, status tracking, and deal analytics on CXII and the full SPAC universe, sign up for SpacDesk.